Pharmaceuticals in Mexico

Date: September 26, 2016
Pages: 38
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P6AAC93B1E6EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Mexico
SUMMARY

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Mexico pharmaceuticals market by value in 2015?
  • What will be the size of the Mexico pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Mexico's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Mexican pharmaceuticals market had total revenues of $8.4bn in 2015, representing a compound annual growth rate (CAGR) of 1.3% between 2011 and 2015.

A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products in Mexico.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.2% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $9.3bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Merck and Co., Inc.
Novartis AG
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Mexico pharmaceuticals market value: $ billion, 2011-15
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Mexico pharmaceuticals market share: % share, by value, 2015
Table 4: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Merck and Co., Inc.: key facts
Table 10: Merck and Co., Inc.: key financials ($)
Table 11: Merck and Co., Inc.: key financial ratios
Table 12: Novartis AG: key facts
Table 13: Novartis AG: key financials ($)
Table 14: Novartis AG: key financial ratios
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: key financials ($)
Table 17: Pfizer Inc.: key financial ratios
Table 18: Mexico size of population (million), 2011-15
Table 19: Mexico gdp (constant 2005 prices, $ billion), 2011-15
Table 20: Mexico gdp (current prices, $ billion), 2011-15
Table 21: Mexico inflation, 2011-15
Table 22: Mexico consumer price index (absolute), 2011-15
Table 23: Mexico exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Mexico pharmaceuticals market value: $ billion, 2011-15
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Mexico pharmaceuticals market share: % share, by value, 2015
Figure 4: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Mexico, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Mexico, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Mexico, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2015
Figure 11: Bayer AG: revenues and profitability
Figure 12: Bayer AG: assets and liabilities
Figure 13: Merck and Co., Inc.: revenues and profitability
Figure 14: Merck and Co., Inc.: assets and liabilities
Figure 15: Novartis AG: revenues and profitability
Figure 16: Novartis AG: assets and liabilities
Figure 17: Pfizer Inc.: revenues and profitability
Figure 18: Pfizer Inc.: assets and liabilities

COMPANIES MENTIONED

Bayer AG
Merck and Co., Inc.
Novartis AG
Pfizer Inc.
Skip to top


OTC Pharmaceuticals in Mexico US$ 350.00 Sep, 2016 · 40 pages
The Pharmaceutical Market: Mexico US$ 1,295.00 Jan, 2013 · 165 pages

Ask Your Question

Pharmaceuticals in Mexico
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: